Laurent Kodjikian, AbbVie/Allergan (C), Alimera/Horus (C), Bayer (C), Novartis (C), Roche (C), Thea (C);
Lluís Arias Barquet, Allergan (C), Bayer (C), Novartis (C), Roche (C), Topcon (C);
András Papp, Allergan (F), Amgen (F), Bayer (F), Bayer (C), Bioeq (F), Chengdu Kanghong (F), Clearside Biomedical (F), Genentech (F), Novartis (F), Novartis (C), Oculis (F), Ophthtotec/Iveric Bio (F), Panoptica (F), Qilu (F), Regeneron (F), Roche (F), Roche (C), Samsung Bioepis (F), Thrombogenics (F), Xbrain (F);
Peter Kertes, Alcon (S), Allergan (F), Allergan (S), ArcticDx (I), Bayer (F), Bayer (S), Novartis (F), Novartis (S), Novelty Nobility (S), Roche (F), Roche (S), Zeiss (F);
Edoardo Midena, Bayer (S);
Jan Ernest, None;
Rufino Silva, Alimera (C), Allergan (C), Bayer (C), Novartis (C), Novo Nordisk (C), Roche (C), Thea (C);
Thomas Schmelter, Bayer (I);
Tobias Niesen, Bayer (I);
Sergio Leal, Bayer (I)